Search Results - "Lim, Farah Louise" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study

Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study

by Neal, Joel W., Santoro, Armando, Gonzalez-Cao, Maria, Lim, Farah Louise, Fang, Bruno, Gentzler, Ryan D., Goldschmidt, Jerome, Khrizman, Polina, Proto, Claudia, Patel, Shiven, Puri, Sonam, Liu, Stephen V., Massarelli, Erminia, Williamson, Denise, Schwickart, Martin, Scheffold, Christian, Andrianova, Svetlana, Felip, Enriqueta
Published in JTO clinical and research reports (01.10.2024)

Get full text

Journal Article

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

by Johnson, Melissa L, Cho, Byoung Chul, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Laktionov, Konstantin, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Shi, Xiaojin, Poole, Lynne, Peters, Solange, Garon, Edward B, Mok, Tony
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

163 - A rare case of primary pulmonary NUT carcinoma with vertebral metastasis

163 - A rare case of primary pulmonary NUT carcinoma with vertebral metastasis

by Ghose, Aruni, Januszewski, Adam, Giaslakiotis, Konstantinos, Thyagarajan, Revathy, Everett, Katherine, Lim, Farah Louise, Conibear, John
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

A case of lymphoepithelial carcinoma of the lung responding to treatment with pembrolizumab, paclitaxel and carboplatin

A case of lymphoepithelial carcinoma of the lung responding to treatment with pembrolizumab, paclitaxel and carboplatin

by Chamberlain, Florence, Sheaff, Michael, Reeves, Annie, Castle, Lianne, Lim, Farah Louise, Januszewski, Adam
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

A rare case of primary pulmonary NUT carcinoma with vertebral metastasis

A rare case of primary pulmonary NUT carcinoma with vertebral metastasis

by Ghose, Aruni, Januszewski, Adam, Giaslakiotis, Konstantinos, Thyagarajan, Revathy, Everett, Katherine, Lim, Farah Louise, Conibear, John
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

160 - A case of lymphoepithelial carcinoma of the lung responding to treatment with pembrolizumab, paclitaxel and carboplatin

160 - A case of lymphoepithelial carcinoma of the lung responding to treatment with pembrolizumab, paclitaxel and carboplatin

by Chamberlain, Florence, Sheaff, Michael, Reeves, Annie, Castle, Lianne, Lim, Farah Louise, Januszewski, Adam
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

89 - Service evaluation of diversity recruitment in thoracic cancer clinical trials at a tertiary cancer centre

89 - Service evaluation of diversity recruitment in thoracic cancer clinical trials at a tertiary cancer centre

by Chamberlain, Florence, Lapuente, Maria, Kirby, Paula, Adebamowo, Ayo, Lau, Kelvin, Ricketts, William, Conibear, John, Steele, Jeremy, Szlosarek, Peter, Lim, Farah Louise, Januszewski, Adam
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

Service evaluation of diversity recruitment in thoracic cancer clinical trials at a tertiary cancer centre

Service evaluation of diversity recruitment in thoracic cancer clinical trials at a tertiary cancer centre

by Chamberlain, Florence, Lapuente, Maria, Kirby, Paula, Adebamowo, Ayo, Lau, Kelvin, Ricketts, William, Conibear, John, Steele, Jeremy, Szlosarek, Peter, Lim, Farah Louise, Januszewski, Adam
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2022)

Get full text

Journal Article

Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts 7 and 20 of the COSMIC-021 study

Cabozantinib (C) plus atezolizumab (A) or C alone in patients (pts) with advanced non–small cell lung cancer (aNSCLC) previously treated with an immune checkpoint inhibitor (ICI): Results from Cohorts 7 and 20 of the COSMIC-021 study

by Neal, Joel W., Santoro, Armando, Viteri, Santiago, Ponce Aix, Santiago, Fang, Bruno, Lim, Farah Louise, Gentzler, Ryan D., Goldschmidt, Jerome H., Khrizman, Polina, Massarelli, Erminia, Patel, Shiven B., Puri, Sonam, Sudhagoni, Ramu, Scheffold, Christian, Curran, Dominic, Felip, Enriqueta
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)

Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)

by Garon, Edward B, Cho, Byoung Chul, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Medic, Nenad, Mann, Helen, Shi, Xiaojin, Peters, Solange, Mok, Tony, Johnson, Melissa
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2023)

Get full text

Journal Article

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial

by Peters, Solange, Cho, Byoung Chul, Luft, Alexander V., Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Laktionov, Konstantin, Trukhin, Dmytro, Kim, Sang-We, Ursol, Grygorii M., Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Lowery, Caitlin, Mann, Helen, Stewart, Ross, Jiang, Haiyi, Garon, Edward B., Mok, Tony, Johnson, Melissa L.
Published in Journal of thoracic oncology (05.09.2024)

Get full text

Journal Article

Durvalumab (D) +/- tremelimumab (T) + chemotherapy (CT) in first-line (1L) metastatic (m) NSCLC: AE management in POSEIDON

Durvalumab (D) +/- tremelimumab (T) + chemotherapy (CT) in first-line (1L) metastatic (m) NSCLC: AE management in POSEIDON

by Cho, Byoung Chul, Reinmuth, Niels, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Trukhin, Dmytro, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen A., Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz H., Saito, Haruhiro, Marotti, Miriam, Barrett, Karen, Shi, Xiaojin, Peters, Solange, Garon, Edward B., Mok, Tony S. K., Johnson, Melissa Lynne
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Cabozantinib in combination with atezolizumab in non-small cell lung cancer (NSCLC) patients previously treated with an immune checkpoint inhibitor: Results from cohort 7 of the COSMIC-021 study

Cabozantinib in combination with atezolizumab in non-small cell lung cancer (NSCLC) patients previously treated with an immune checkpoint inhibitor: Results from cohort 7 of the COSMIC-021 study

by Neal, Joel W., Lim, Farah Louise, Felip, Enriqueta, Gentzler, Ryan D., Patel, Shiven B., Baranda, Joaquina, Fang, Bruno, Squillante, Christian Michael, Simonelli, Matteo, Werneke, Scott, Curran, Dominic, Ponce Aix, Santiago
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

Novel therapies in oestrogen receptor positive breast cancer

Novel therapies in oestrogen receptor positive breast cancer

by Lim, Farah Louise
Year of Publication 2021

Get full text

Dissertation

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

by Garon, Edward B, Cho, Byoung Chul, Luft, Alexander, Alatorre-Alexander, Jorge, Geater, Sarayut Lucien, Trukhin, Dmytro, Kim, Sang-We, Ursol, Grygorii, Hussein, Maen, Lim, Farah Louise, Yang, Cheng-Ta, Araujo, Luiz Henrique, Saito, Haruhiro, Reinmuth, Niels, Kohlmann, Milena, Lowery, Caitlin, Mann, Helen, Peters, Solange, Mok, Tony S, Johnson, Melissa L
Published in Clinical lung cancer (01.05.2024)

Get full text

Journal Article

Abstract CT201: Phase Ib/II open-label, randomized evaluation of atezolizumab + cobimetinib vs control in MORPHEUS-NSCLC (non-small cell lung cancer), MORPHEUS-PDAC (pancreatic ductal adenocarcinoma) and MORPHEUS-GC (gastric cancer)

Abstract CT201: Phase Ib/II open-label, randomized evaluation of atezolizumab + cobimetinib vs control in MORPHEUS-NSCLC (non-small cell lung cancer), MORPHEUS-PDAC (pancreatic ductal adenocarcinoma) and MORPHEUS-GC (gastric cancer)

by Cho, Byoung Chul, Bahary, Nathan, Bendell, Johanna, Felip, Enriqueta, Johnson, Melissa, Kang, Yoon-Koo, Lim, Farah Louise, Macarulla, Teresa, Manji, Gulam, Oh, Do-Youn, Rahma, Osama, Allen, Simon, Cha, Edward, Cotting, Denise, Helms, Hans-Joachim, Pintoffl, Jan, Sayyed, Pakeeza, Zhang, Xiaosong, Kim, Kyu-pyo
Published in Cancer research (Chicago, Ill.) (15.08.2020)

Get full text

Journal Article